title: Methodologic diligence is needed to define and validate tumor-size response metrics to predict overall survival in first-line metastatic colorectal cancer.
authors.affiliation: Ludwig Maximilians University, Munich, Germany.
authors.forename: Ulrich R
authors.initials: UR
authors.lastname: Mansmann
authors.forename: Rüdiger P
authors.initials: RP
authors.lastname: Laubender
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D005260:Female; D006801:Humans; D008297:Male